SILAM for quantitative proteomics of liver Akt1/PKBα after burn injury

International Journal of Molecular Medicine

Volumn 29, Issue 3, 2012, Pages 461-471

  Lu, X M ^a,b,c   Tompkins, R G ^a,b,c   Fischman, A J ^b,c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c SHRINERS HOSPITALS FOR CHILDREN   (United States)

Author keywords

Akt1 PKB ; Burn injury; MS MS; SILAM

Indexed keywords

ALBUMIN; AMYLOID P COMPONENT; CYSTINE; LEUCINE; LIVER EXTRACT; PROTEIN KINASE B; PROTEIN KINASE B ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BURN; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; IMMUNOPRECIPITATION; ISOTOPE LABELING; LIQUID CHROMATOGRAPHY; LIVER; MALE; MOUSE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; PROTEOMICS; STABLE ISOTOPE LABELING BY AMINO ACID IN MAMMALIAN; TANDEM MASS SPECTROMETRY; TIME OF FLIGHT MASS SPECTROMETRY;

AMINO ACIDS; ANIMALS; BURNS; ISOTOPE LABELING; LIVER; MALE; MASS SPECTROMETRY; MICE; PROTEOMICS; PROTO-ONCOGENE PROTEINS C-AKT; SERUM ALBUMIN; SERUM AMYLOID P-COMPONENT;

EID: 84856193454     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2011.861     Document Type: Article

References (63)

1. Beynon RJ and Pratt JM: Metabolic labeling of proteins for proteomics. Mol Cell Proteomics 4: 857-872, 2005. (Pubitemid 41309145)
2. Harsha HC, Molina H and Pandey A: Quantitative proteomics using stable isotope labeling with amino acids in cell culture. Nat Protoc 3: 505-516, 2008. (Pubitemid 351372235)
3. Beynon RJ: The dynamics of the proteome: strategies for measuring protein turnover on a proteome-wide scale. Brief Funct Genomic Proteomic 3: 382-390, 2005.
4. Moresco JJ, Dong MQ and Yates JR: Quantitative mass spectrometry as a tool for nutritional proteomics. Am J Clin Nutr 88: 597-604, 2008.
5. Nair KS, Jaleel A, Asmann YW, Short KR and Raghavakaimal-S: Proteomic research: potential opportunities for clinical and physiological investigators. Am J Physiol Endocrinol Metab 286: E863-E874, 2004.
6. Krijgsveld J, Ketting RF, Mahmoudi T, Johansen J, Artal-Sanz-M, Verrijzer-CP, Plasterk RH and Heck AJ: Metabolic labeling of C.- elegans and D. melanogaster for quantitative proteomics. Nat Biotech 21: 927-931, 2003. (Pubitemid 36936200)
7. Doherty MK, Whitehead C, McCormack H, Gaskell SJ and Beynon-RJ: Proteome dynamics in complex organisms: using stable isotopes to monitor individual protein turnover rates. Proteomics 5: 522-533, 2005.
8. Hayter JR, Doherty MK, Whitehead C, McCormack-H, Gaskell-SJ and Beynon RJ: The subunit structure and dynamics of the 20S proteasome in chicken skeletal muscle. Mol Cell Proteomics 4: 1370-1381, 2005. (Pubitemid 41448723)
9. Wu CC, MacCoss MJ, Howell KE, Matthews DE and Yates-JR-III: Metabolic labeling of mammalian organisms with stable isotopes for quantitative proteomic analysis. Anal Chem 76: 4951-4959, 2004.
10. Kruger M, Moser M, Ussar S, Thievessen I, Luber CA, Former-F, Schmidt-S, Zanivan S, Fassler R and Mann M: SILAC mouse for quantitative proteomics uncovers kindling-3 as an essential factor for red blood cell function. Cell 134: 353-364, 2008. (Pubitemid 352010327)
11. 15N-labeled proteins in comparative proteomics. Anal Chem 80: 7796-7803, 2008.
12. Huttlin EL, Hegeman AD, Harms AC and Sussman-MR: Comparison of full versus partial metabolic labeling for quantitative proteomics analysis in Arabidopsis thaliana. Mol Cell Proteomics 6: 860-881, 2007.
13. 15N Metabolic labeling of mammalian tissue with slow protein turnover. J Proteome Res 6: 2005-2010, 2005.
14. Liao L, McClatchy DB, Park SK, Xu T, Lu B and Yates JR-III: Quantitative analysis of brain nuclear phosphoproteins identifies developmentally regulated phosphorylation events. J Proteome Res 7: 4743-4755, 2008.
15. Bachi A and Bonaldi T: Quantitative proteomics as a new piece of the systems biology puzzle. J Proteomics 71: 357-367, 2008.
16. Biolo G, Fleming RY, Maggi SP, Nguyen TT, Herndon DN and Wolfe-RR: Inverse regulation of protein turnover and amino acid transport in skeletal muscle of hypercatabolic patients. J Clin Endocrinol Metab 87: 3378-3384, 2002.
17. Bodine SC, Stitt TN, Gonzalez M, Kline WO, Stover-GL, Bauerlein-R, Zlotchenko E, Scrimgeour A, Lawrence-JC, Glass-DJ and Yancopoulos GD: Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in-vivo. Nat Cell Biol 3: 1014-1019, 2001. (Pubitemid 34428747)
18. Bruning JC, Winnay J, Cheatham B and Kahn CR: Differential signaling by insulin receptor substrate 1 (IRS-1) and IRS-2 in IRS-1-deficient cells. Mol Cell Biol 17: 1513-1521, 1997. (Pubitemid 27097381)
19. Carvalho E, Rondinone C and Smith U: Insulin resistance in fat cells from obese Zucker rats - evidence for an impaired activation and translocation of protein kinase B and glucose transporter 4. Mol Cell Biochem 206: 7-16, 2000. (Pubitemid 30246501)
20. Araki E, Lipes MA, Patti ME, Bruning JC, Haag B, Johnson-RS and Kahn CR: Alternative pathway of insulin signaling in mice with targeted disruption of the IRS-1 gene. Nature 372: 186-190, 1994. (Pubitemid 24347839)
21. Khoury W, Klausner JM, Benabraham R and Szold O: Glucose control by insulin for critically ill surgical patients. J Trauma 57: 1132-1138, 2004. (Pubitemid 39579309)
22. Carter EA, Burks D, Fischman AJ, White M and Tompkins-RG: Insulin resistance in thermally-injured rats is associated with post-receptor alterations in skeletal muscle, liver and adipose tissue. Int J Mol Med 14: 653-658, 2004.
23. Groeneveld AB, Beishuizen A and Visser FC: Insulin: a wonder drug in the critically ill? Critical Care 6: 102-105, 2002. (Pubitemid 34296333)
24. Ikezu T, Okamato T, Yonezawa K, Tompkins RG and Martyn-JA: Analysis of thermal injury-induced insulin resistance in rodents. J Biol Chem 272: 25289-25295, 1997.
25. White MF: Insulin signaling in health and disease. Science 302: 1710-1711, 2003.
26. Zhang Q, Carter EA, Ma BY, White M, Fischman AJ and Tompkins-RG: Molecular mechanism(s) of burn-induced insulin resistance in murine skeletal muscle: role of IRS phosphorylation. Life Sci 77: 3068-3077, 2005.
27. Ishiki M and Klip A: Minireview: recent developments in the regulation of glucose transporter-4 traffic: new signals, locations, and partners. Endocrinology 146: 5071-5078, 2005. (Pubitemid 41653019)
28. Kaneki M, Shimizu N, Yamada D and Chang K: Nitrosative stress and pathogenesis of insulin resistance. Antioxid Redox Signal 9: 1-11, 2007.
29. Song G, Quyang G and Bao S: The activation of Akt/PKB signaling pathway and cell survival. J Cell Mol Med 9: 59-71, 2005.
30. Neels JG and Olefsky JM: A new way to burn fat. Science 312: 1756-1758, 2006. (Pubitemid 43962882)
31. Tian R: Another role for celebrity, Akt and insulin resistance. Circ Res 96: 139-140, 2006.
32. Lawlor MA and Alessi DR: PKB/Akt: a key mediator of cell proliferation, survival and insulin responses? J Cell Sci 114: 2903-2910, 2001. (Pubitemid 32821530)
33. Yang J, Cron P, Thompson V, Good VM, Hess D, Hemmings-BA and Barford D: Molecular mechanism for the regulation of protein kinase B/Akt by hydrophobic motif phosphorylation. Mol Cell 9: 1227-1240, 2002. (Pubitemid 34722302)
34. Yang J, Cron P, Good VM, Thompson V, Hemmings BA and Barford-D: Crystal structure of an activated Akt/protein kinase-B ternary complex with GSK3-peptide and AMP-PNP. Nat Structure Biol 9: 940-944, 2002.
35. Huang X, Begley M, Morgenstern KA, Gu Y, Rose P, Zhao-H and Zhu-X: Crystal structure of an inactive Akt2 kinase domain. Structure 11: 21-30, 2003. (Pubitemid 36071494)
36. Kumar CC and Madison V: Akt crystal structure and Akt-specific inhibitors. Oncogene 24: 7493-7501, 2005. (Pubitemid 41637989)
37. Fayard E, Tintignac LA, Baudry A and Hemmings BA: Protein kinase B/Akt at a glance. J Cell Sci 118: 5675-5678, 2005. (Pubitemid 43079259)
38. Brazil DP, Yang ZZ and Hemmings BA: Advances in protein kinase B signaling: AKTion on multiple fronts. Trends Biochem Sci 29: 233-242, 2005.
39. Brazil DP, Park J and Hemmings BA: PKB binding proteins: getting in on the Akt. Cell 111: 293-303, 2002. (Pubitemid 35341386)
40. Huang BX and Kim HY: Interdomain conformational changes in Akt activation revealed by chemical cross-linking and tandem mass spectrometry. Mol Cellular Proteomics 5: 1045-1053, 2006. (Pubitemid 43985929)
41. Sugita H, Kaneki M, Sugita M, Yasukawa T, Yasuhara S and Martyn-JA: Burn injury impairs insulin-stimulated Akt/PKB activation in skeletal muscle. Am J Physiol Endocrinol Metab 288: E585-E591, 2004.
42. Carvalho-Filho MA, Ueno M, Hirabara SM, Seabra-AB, Carvalheira-JB, de Oliveira MG, Velloso LA, Curi R and Saad-MJ: S-nitrosation of the insulin receptor, insulin receptor substrate 1, and protein kinase B/Akt: a novel mechanism of insulin resistance. Diabetes 54: 959-967, 2005. (Pubitemid 40446309)
43. Yasukawa T, Tokunaga, E, Ota H, Sugita H, Martyn JA and Kaneki-M: S-Nitrosylation-dependent inactivation of Akt/protein kinase B in insulin resistance. J Biol Chem 280: 7511-7518, 2005.
44. Carter EA, Derojas-Walker T, Tamir S, Tannenbaum SR, Yu-YM and Tompkins RG: Nitric oxide production is intensely and persistently increased in tissue by thermal injury. Biochem J 304: 201-204, 1994. (Pubitemid 24354245)
45. Auguin D, Barthe P, Auge-Senegas MT, Stern MH, Noguchi-M and Roumestand C: Solution structure and backbone dynamics of the Pleckstrin homology domain of the human protein kinase B (PKB/Akt). Interaction with inositol phosphates. J Biomol NMR 28: 137-155, 2004. (Pubitemid 38232793)
46. Murata H, Ihara Y, Nakamura H, Yodoi J, Sumikawa K and Kondo-T: Glotaredoxin exerts an antiapoptotic effect by regulating the redox state of Akt. J Biol Chem 278: 50226-50233, 2003.
47. Lu XM, Lu M, Fischman AJ and Tompkins RG: A new approach for sequencing human IRS1 phosphotyrosine-containing peptides using CapLC-Q-TOF micro mass spectrometry. J Mass Spectrom 40: 599-607, 2005. (Pubitemid 40733317)
48. Lu XM, Lu M, Tompkins RG and Fischman AJ: Site-specific detection of S-nitrosylated PKBa/Akt1 from rat soleus muscle using CapLC-Q-TOF micro mass spectrometry. J Mass Spectrom 40: 1140-1148, 2005. (Pubitemid 41337242)
49. Jaffrey SR, Erdjument-Bromage H, Ferris CD, Tempst-P and Snyder-SH: Protein S-nitrosylation: a physiological signal for neuronal nitric oxide. Nat Cell Biol 3: 193-197, 2001. (Pubitemid 32118373)
50. Jaffrey SR and Snyder SH: The biotin switch method for detection of S-nitrosylated proteins. Science STKE 86: 1-9, 2001.
51. Greco TM, Hodara R, Parastatidis I, Heijnen HFG, Dennehy-MK, Liebler-DC and Ischiropoulos H: Identification of S-nitrosylation motifs by site-specific mapping of the S-nitrosocysteine proteome in human vascular smooth muscle cells. Proc Natl Acad Sci USA 103: 7420-7425, 2006. (Pubitemid 43727848)
52. Hao G, Derakhshan B, Shi L, Campagne F and Gross-SS: SNOSID, a proteomic method for identification of cysteine S-nitrosylation sites in complex protein mixtures. Proc Natl Acad Sci USA 103: 1012-1017, 2006.
53. Kuncewicz T, Sheta EA, Goldknopf IL and Kone BC: Proteomic analysis of S-nitrosylated proteins in mesangial cell. Mol Cellular Proteomics 2: 156-163, 2003.
54. Martinez-Ruiz A and Lamas S: Detection and proteomic identification of S-nitrosylated proteins in endothelial cells. Arch Biochem Biophys 423: 192-199, 2004. (Pubitemid 38198228)
55. Carter EA, Tompkins RG, Babich JW, Correia J, Bailey EM and Fischman-AJ: Thermal injury in rats alters glucose utilization by skin, wound, and small intestine, but not by skeletal muscle. Metabolism 45: 1161-1167, 1996.
56. Vogt JA, Hunzinger C, Schroer K, Holzer K, Bauer-A, Schrattenholz-A, Cahill MA, Schillo S, Schwall G, Stegmann-W and Albuszies-G: Determination of fractional synthesis rates of mouse hepatic proteins via metabolic 13C-labeling, MALDI-TOF MS and analysis of relative isotopologue abundances using average masses. Anal Chem 77: 2034-2042, 2005. (Pubitemid 40463818)
57. 15N amino acid labeling in pancreatic cancer cells. Anal Chem 81: 764-771, 2009.
58. Cho H, Thorvaldsen JL, Chu Q, Feng F and Brinbaum MJ: Akt1/PKBalpha is required for normal growth but dispensable for maintenance of glucose homeostasis in mice. J Biol Chem 276: 38349-38352, 2001.
59. Chi H, Mu J, Kim JK, Thorvaldsen JL, Chu Q, Crenshaw-EB, Kaestner-KH, Bartolomer MS, Shulman GI and Birnbaum-MJ: Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta). Science 292: 1728-1731, 2001. (Pubitemid 32506248)
60. Wilson EM and Rotwein P: Selective control of skeletal muscle differentiation by Akt1. J Biol Chem 282: 5106-5110, 2007. (Pubitemid 47093711)
61. Rotwein P and Wilson EM: Distinct actions of Akt1 and Akt2 in skeletal muscle differentiation. J Cell Physiol 219: 503-511, 2009.
62. Gan HT and Chen JD: Roles of nitric oxide and prostaglandins in pathogenesis of delayed colonic transit after burn injury in rats. Am J Physiol Regul Integr Comp Physiol 288: R1316-R1324, 2005. (Pubitemid 40593716)
63. Torres SH, Sanctis JB, de L Briceno M, Hernandez N and Finol-HJ: Inflammation and nitric oxide production in skeletal muscle of type 2 diabetic patients. J Endocrinol 181: 419-427, 2004. (Pubitemid 38868192)